Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The overall goal of this project is to determine if high dose vitamin D3 given to
premenopausal women at high risk for development of breast cancer, who initially have
insufficient levels of 25-hydroxy vitamin D (<30 ng/ml), will raise 25(OH)D levels above 50
ng/ml. If so, will certain risk biomarkers for development of breast cancer be reliably and
favorably modulated?
Phase:
N/A
Details
Lead Sponsor:
Carol Fabian, MD
Collaborator:
BTR Group
Treatments:
Cholecalciferol Ergocalciferols Molecular Mechanisms of Pharmacological Action Vitamin D Vitamins